- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01792947
Percutaneous Electroneurostimulation of Dermatome T6 for Appetite Reduction and Weight Loss in Morbidly Obese Patients
Based on the creation of a somato-autonomic reflex, the stimulation of sensory nerve terminals located in dermatome T6 may cause a reflex, whose efferent pathways end in vagal nerve branches stimulating the gastric wall, similarly to the gastric pacemaker.
The aim of this study was to evaluate the effect of percutaneous electroneurostimulation (PENS) of T6 dermatome on appetite, weight loss and dietary compliance.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alicante
-
Elche, Alicante, Spain, 03202
- Hospital General Universitario de Elche
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patients candidates to bariatric surgery
- BMI > 40 Kg/m2 or a BMI > 35 Kg/m2 with comorbidities associated to the obesity status
- Failure of dietary treatment.
Exclusion Criteria:
- untreated endocrine disease causing obesity
- serious psychiatric illness.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Diet
Diet 1200 Kcal during 3 months
|
The patients assigned to this group must follow a 1200 Kcal diet during months
|
Experimental: PENS associated to diet
Percutaneous electroneurostimulation of dermatome T6 associated to diet 1200 Kcal
|
The patients assigned to this group must follow a 1200 Kcal diet during months
The patients underwent a percutaneous electroneurostimulation of dermatome T6 during 30 minutes, every week during 12 weeks.
This intervention was associated to a diet 1200 Kcal
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Appetite reduction
Time Frame: 3 months
|
The appetite reduction will be measured asking the patient to quantify the appetite sensation according to a visula analogic scale, ranged from 0 (absence of appetite) to 10 (incontrolable appetite).
Appetite will be measured before the beginning of the treatment and after finishing it (after 12 weeks of treatment).
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Weight loss
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Jaime Ruiz-Tovar, MD, PhD, General University Hospital Elche
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HGUE2013-1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Weight Loss
-
United States Army Research Institute of Environmental...USDA Grand Forks Human Nutrition Research Center; Eastern Michigan UniversityCompletedWeight Loss | Bone Loss | Muscle LossUnited States
-
Case Comprehensive Cancer CenterUniversity Hospitals Seidman Cancer CenterRecruitingUnintentional Weight Loss and Cancer: A Prospective Trial of Patient-centered Weight Tracking CombinUnintended Weight LossUnited States
-
Zhen Jun WangUnknownSleeve Gastrectomy | Excessive Weight Loss | Total Weight Loss | Jejunojejunal Bypass | UncutChina
-
HealthPartners InstituteNational Cancer Institute (NCI)Completed
-
Dana-Farber Cancer InstituteCompletedWeight Loss Program After Cancer DiagnosisUnited States
-
Medical University of ViennaCompleted
-
University at BuffaloHarvard Medical School (HMS and HSDM)TerminatedWeight Loss | Appetite LossUnited States
-
Power Life Sciences Inc.Not yet recruitingGastric Bypass | Weight Loss Surgery
-
Duke UniversityNational Institute on Aging (NIA)Suspended
-
University of AarhusToyota-Fonden; Orkla Health; Tømmerhandler Vilhelm Bangs FondCompletedMuscle Loss
Clinical Trials on Diet 1200 Kcal
-
Hospital General Universitario ElcheCompleted
-
Hospital General Universitario ElcheCompletedDiabetes Mellitus Type 2 in Obese | Type 2 Diabetes Mellitus With Features of Insulin ResistanceSpain
-
Abdel Kadar ClinicCompleted
-
Chang Gung Memorial HospitalRecruitingObesity | Osteoarthritis, Knee | Diet, Healthy | Training Group, SensitivityTaiwan
-
Imperial College LondonRecruitingObesity | Eating Behavior | Appetitive BehaviorUnited Kingdom
-
Hospital Severo OchoaInstituto de Salud Carlos IIICompleted
-
King's College Hospital NHS TrustUnknown
-
Pennington Biomedical Research CenterCompleted
-
University of PennsylvaniaRecruitingAlcohol Drinking | Magnetic Resonance Imaging | Ketoses, Metabolic | Ketogenic Dieting | Alcohol IntoxicationUnited States
-
Aarhus University HospitalUnknown